Global Human Rotavirus Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Human Rotavirus Vaccine market size was valued at USD 193.4 million in 2023 and is forecast to a readjusted size of USD 240.5 million by 2030 with a CAGR of 3.2% during review period.
Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease.
Rotavirus vaccine is administered by mouth and requires two or three doses starting around six weeks of age. The vaccine first became available in the United States in 2006.
The Global Info Research report includes an overview of the development of the Human Rotavirus Vaccine industry chain, the market status of Hospitals & Clinics (Rotarix, RotaTeq), Academic And Research (Rotarix, RotaTeq), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Human Rotavirus Vaccine.
Regionally, the report analyzes the Human Rotavirus Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Human Rotavirus Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Human Rotavirus Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Human Rotavirus Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Rotarix, RotaTeq).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Human Rotavirus Vaccine market.
Regional Analysis: The report involves examining the Human Rotavirus Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Human Rotavirus Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Human Rotavirus Vaccine:
Company Analysis: Report covers individual Human Rotavirus Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Human Rotavirus Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals & Clinics, Academic And Research).
Technology Analysis: Report covers specific technologies relevant to Human Rotavirus Vaccine. It assesses the current state, advancements, and potential future developments in Human Rotavirus Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Human Rotavirus Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Human Rotavirus Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Human Rotavirus Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Rotavirus Vaccine, with price, sales, revenue and global market share of Human Rotavirus Vaccine from 2019 to 2024.
Chapter 3, the Human Rotavirus Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Rotavirus Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Human Rotavirus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Rotavirus Vaccine.
Chapter 14 and 15, to describe Human Rotavirus Vaccine sales channel, distributors, customers, research findings and conclusion.
Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease.
Rotavirus vaccine is administered by mouth and requires two or three doses starting around six weeks of age. The vaccine first became available in the United States in 2006.
The Global Info Research report includes an overview of the development of the Human Rotavirus Vaccine industry chain, the market status of Hospitals & Clinics (Rotarix, RotaTeq), Academic And Research (Rotarix, RotaTeq), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Human Rotavirus Vaccine.
Regionally, the report analyzes the Human Rotavirus Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Human Rotavirus Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Human Rotavirus Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Human Rotavirus Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Rotarix, RotaTeq).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Human Rotavirus Vaccine market.
Regional Analysis: The report involves examining the Human Rotavirus Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Human Rotavirus Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Human Rotavirus Vaccine:
Company Analysis: Report covers individual Human Rotavirus Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Human Rotavirus Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals & Clinics, Academic And Research).
Technology Analysis: Report covers specific technologies relevant to Human Rotavirus Vaccine. It assesses the current state, advancements, and potential future developments in Human Rotavirus Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Human Rotavirus Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Human Rotavirus Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Rotarix
- RotaTeq
- Rotavac
- Rotavin-M1
- Lanzhou lamb
- Others
- Hospitals & Clinics
- Academic And Research
- Others
- Bharat Biotech
- Merck
- GlaxoSmithKline
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Human Rotavirus Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Rotavirus Vaccine, with price, sales, revenue and global market share of Human Rotavirus Vaccine from 2019 to 2024.
Chapter 3, the Human Rotavirus Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Rotavirus Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Human Rotavirus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Rotavirus Vaccine.
Chapter 14 and 15, to describe Human Rotavirus Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Human Rotavirus Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Rotavirus Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Rotarix
1.3.3 RotaTeq
1.3.4 Rotavac
1.3.5 Rotavin-M1
1.3.6 Lanzhou lamb
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Rotavirus Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals & Clinics
1.4.3 Academic And Research
1.4.4 Others
1.5 Global Human Rotavirus Vaccine Market Size & Forecast
1.5.1 Global Human Rotavirus Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Human Rotavirus Vaccine Sales Quantity (2019-2030)
1.5.3 Global Human Rotavirus Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Bharat Biotech
2.1.1 Bharat Biotech Details
2.1.2 Bharat Biotech Major Business
2.1.3 Bharat Biotech Human Rotavirus Vaccine Product and Services
2.1.4 Bharat Biotech Human Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bharat Biotech Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Human Rotavirus Vaccine Product and Services
2.2.4 Merck Human Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck Recent Developments/Updates
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Human Rotavirus Vaccine Product and Services
2.3.4 GlaxoSmithKline Human Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GlaxoSmithKline Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HUMAN ROTAVIRUS VACCINE BY MANUFACTURER
3.1 Global Human Rotavirus Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Human Rotavirus Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Human Rotavirus Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Human Rotavirus Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Human Rotavirus Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Human Rotavirus Vaccine Manufacturer Market Share in 2023
3.5 Human Rotavirus Vaccine Market: Overall Company Footprint Analysis
3.5.1 Human Rotavirus Vaccine Market: Region Footprint
3.5.2 Human Rotavirus Vaccine Market: Company Product Type Footprint
3.5.3 Human Rotavirus Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Human Rotavirus Vaccine Market Size by Region
4.1.1 Global Human Rotavirus Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Human Rotavirus Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Human Rotavirus Vaccine Average Price by Region (2019-2030)
4.2 North America Human Rotavirus Vaccine Consumption Value (2019-2030)
4.3 Europe Human Rotavirus Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Human Rotavirus Vaccine Consumption Value (2019-2030)
4.5 South America Human Rotavirus Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Human Rotavirus Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Human Rotavirus Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Human Rotavirus Vaccine Consumption Value by Type (2019-2030)
5.3 Global Human Rotavirus Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Human Rotavirus Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Human Rotavirus Vaccine Consumption Value by Application (2019-2030)
6.3 Global Human Rotavirus Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Human Rotavirus Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Human Rotavirus Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Human Rotavirus Vaccine Market Size by Country
7.3.1 North America Human Rotavirus Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Human Rotavirus Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Human Rotavirus Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Human Rotavirus Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Human Rotavirus Vaccine Market Size by Country
8.3.1 Europe Human Rotavirus Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Human Rotavirus Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Human Rotavirus Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Human Rotavirus Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Human Rotavirus Vaccine Market Size by Region
9.3.1 Asia-Pacific Human Rotavirus Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Human Rotavirus Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Human Rotavirus Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Human Rotavirus Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Human Rotavirus Vaccine Market Size by Country
10.3.1 South America Human Rotavirus Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Human Rotavirus Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Human Rotavirus Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Human Rotavirus Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Human Rotavirus Vaccine Market Size by Country
11.3.1 Middle East & Africa Human Rotavirus Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Human Rotavirus Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Human Rotavirus Vaccine Market Drivers
12.2 Human Rotavirus Vaccine Market Restraints
12.3 Human Rotavirus Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Human Rotavirus Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Rotavirus Vaccine
13.3 Human Rotavirus Vaccine Production Process
13.4 Human Rotavirus Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Rotavirus Vaccine Typical Distributors
14.3 Human Rotavirus Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Human Rotavirus Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Rotavirus Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Rotarix
1.3.3 RotaTeq
1.3.4 Rotavac
1.3.5 Rotavin-M1
1.3.6 Lanzhou lamb
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Rotavirus Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals & Clinics
1.4.3 Academic And Research
1.4.4 Others
1.5 Global Human Rotavirus Vaccine Market Size & Forecast
1.5.1 Global Human Rotavirus Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Human Rotavirus Vaccine Sales Quantity (2019-2030)
1.5.3 Global Human Rotavirus Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Bharat Biotech
2.1.1 Bharat Biotech Details
2.1.2 Bharat Biotech Major Business
2.1.3 Bharat Biotech Human Rotavirus Vaccine Product and Services
2.1.4 Bharat Biotech Human Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bharat Biotech Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Human Rotavirus Vaccine Product and Services
2.2.4 Merck Human Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck Recent Developments/Updates
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Human Rotavirus Vaccine Product and Services
2.3.4 GlaxoSmithKline Human Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GlaxoSmithKline Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HUMAN ROTAVIRUS VACCINE BY MANUFACTURER
3.1 Global Human Rotavirus Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Human Rotavirus Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Human Rotavirus Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Human Rotavirus Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Human Rotavirus Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Human Rotavirus Vaccine Manufacturer Market Share in 2023
3.5 Human Rotavirus Vaccine Market: Overall Company Footprint Analysis
3.5.1 Human Rotavirus Vaccine Market: Region Footprint
3.5.2 Human Rotavirus Vaccine Market: Company Product Type Footprint
3.5.3 Human Rotavirus Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Human Rotavirus Vaccine Market Size by Region
4.1.1 Global Human Rotavirus Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Human Rotavirus Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Human Rotavirus Vaccine Average Price by Region (2019-2030)
4.2 North America Human Rotavirus Vaccine Consumption Value (2019-2030)
4.3 Europe Human Rotavirus Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Human Rotavirus Vaccine Consumption Value (2019-2030)
4.5 South America Human Rotavirus Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Human Rotavirus Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Human Rotavirus Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Human Rotavirus Vaccine Consumption Value by Type (2019-2030)
5.3 Global Human Rotavirus Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Human Rotavirus Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Human Rotavirus Vaccine Consumption Value by Application (2019-2030)
6.3 Global Human Rotavirus Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Human Rotavirus Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Human Rotavirus Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Human Rotavirus Vaccine Market Size by Country
7.3.1 North America Human Rotavirus Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Human Rotavirus Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Human Rotavirus Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Human Rotavirus Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Human Rotavirus Vaccine Market Size by Country
8.3.1 Europe Human Rotavirus Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Human Rotavirus Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Human Rotavirus Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Human Rotavirus Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Human Rotavirus Vaccine Market Size by Region
9.3.1 Asia-Pacific Human Rotavirus Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Human Rotavirus Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Human Rotavirus Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Human Rotavirus Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Human Rotavirus Vaccine Market Size by Country
10.3.1 South America Human Rotavirus Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Human Rotavirus Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Human Rotavirus Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Human Rotavirus Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Human Rotavirus Vaccine Market Size by Country
11.3.1 Middle East & Africa Human Rotavirus Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Human Rotavirus Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Human Rotavirus Vaccine Market Drivers
12.2 Human Rotavirus Vaccine Market Restraints
12.3 Human Rotavirus Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Human Rotavirus Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Rotavirus Vaccine
13.3 Human Rotavirus Vaccine Production Process
13.4 Human Rotavirus Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Rotavirus Vaccine Typical Distributors
14.3 Human Rotavirus Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Human Rotavirus Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Human Rotavirus Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 4. Bharat Biotech Major Business
Table 5. Bharat Biotech Human Rotavirus Vaccine Product and Services
Table 6. Bharat Biotech Human Rotavirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Bharat Biotech Recent Developments/Updates
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Major Business
Table 10. Merck Human Rotavirus Vaccine Product and Services
Table 11. Merck Human Rotavirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Merck Recent Developments/Updates
Table 13. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline Major Business
Table 15. GlaxoSmithKline Human Rotavirus Vaccine Product and Services
Table 16. GlaxoSmithKline Human Rotavirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. GlaxoSmithKline Recent Developments/Updates
Table 18. Global Human Rotavirus Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 19. Global Human Rotavirus Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 20. Global Human Rotavirus Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 21. Market Position of Manufacturers in Human Rotavirus Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 22. Head Office and Human Rotavirus Vaccine Production Site of Key Manufacturer
Table 23. Human Rotavirus Vaccine Market: Company Product Type Footprint
Table 24. Human Rotavirus Vaccine Market: Company Product Application Footprint
Table 25. Human Rotavirus Vaccine New Market Entrants and Barriers to Market Entry
Table 26. Human Rotavirus Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 27. Global Human Rotavirus Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 28. Global Human Rotavirus Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 29. Global Human Rotavirus Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 30. Global Human Rotavirus Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 31. Global Human Rotavirus Vaccine Average Price by Region (2019-2024) & (USD/Unit)
Table 32. Global Human Rotavirus Vaccine Average Price by Region (2025-2030) & (USD/Unit)
Table 33. Global Human Rotavirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 34. Global Human Rotavirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 35. Global Human Rotavirus Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 36. Global Human Rotavirus Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 37. Global Human Rotavirus Vaccine Average Price by Type (2019-2024) & (USD/Unit)
Table 38. Global Human Rotavirus Vaccine Average Price by Type (2025-2030) & (USD/Unit)
Table 39. Global Human Rotavirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 40. Global Human Rotavirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 41. Global Human Rotavirus Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 42. Global Human Rotavirus Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 43. Global Human Rotavirus Vaccine Average Price by Application (2019-2024) & (USD/Unit)
Table 44. Global Human Rotavirus Vaccine Average Price by Application (2025-2030) & (USD/Unit)
Table 45. North America Human Rotavirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 46. North America Human Rotavirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 47. North America Human Rotavirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 48. North America Human Rotavirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 49. North America Human Rotavirus Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 50. North America Human Rotavirus Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 51. North America Human Rotavirus Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 52. North America Human Rotavirus Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 53. Europe Human Rotavirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 54. Europe Human Rotavirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 55. Europe Human Rotavirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 56. Europe Human Rotavirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 57. Europe Human Rotavirus Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 58. Europe Human Rotavirus Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 59. Europe Human Rotavirus Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 60. Europe Human Rotavirus Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 61. Asia-Pacific Human Rotavirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 62. Asia-Pacific Human Rotavirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 63. Asia-Pacific Human Rotavirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 64. Asia-Pacific Human Rotavirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 65. Asia-Pacific Human Rotavirus Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 66. Asia-Pacific Human Rotavirus Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 67. Asia-Pacific Human Rotavirus Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 68. Asia-Pacific Human Rotavirus Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 69. South America Human Rotavirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 70. South America Human Rotavirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 71. South America Human Rotavirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 72. South America Human Rotavirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 73. South America Human Rotavirus Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 74. South America Human Rotavirus Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 75. South America Human Rotavirus Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 76. South America Human Rotavirus Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 77. Middle East & Africa Human Rotavirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 78. Middle East & Africa Human Rotavirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 79. Middle East & Africa Human Rotavirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 80. Middle East & Africa Human Rotavirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 81. Middle East & Africa Human Rotavirus Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 82. Middle East & Africa Human Rotavirus Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 83. Middle East & Africa Human Rotavirus Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 84. Middle East & Africa Human Rotavirus Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 85. Human Rotavirus Vaccine Raw Material
Table 86. Key Manufacturers of Human Rotavirus Vaccine Raw Materials
Table 87. Human Rotavirus Vaccine Typical Distributors
Table 88. Human Rotavirus Vaccine Typical Customers
Table 1. Global Human Rotavirus Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Human Rotavirus Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 4. Bharat Biotech Major Business
Table 5. Bharat Biotech Human Rotavirus Vaccine Product and Services
Table 6. Bharat Biotech Human Rotavirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Bharat Biotech Recent Developments/Updates
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Major Business
Table 10. Merck Human Rotavirus Vaccine Product and Services
Table 11. Merck Human Rotavirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Merck Recent Developments/Updates
Table 13. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline Major Business
Table 15. GlaxoSmithKline Human Rotavirus Vaccine Product and Services
Table 16. GlaxoSmithKline Human Rotavirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. GlaxoSmithKline Recent Developments/Updates
Table 18. Global Human Rotavirus Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 19. Global Human Rotavirus Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 20. Global Human Rotavirus Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 21. Market Position of Manufacturers in Human Rotavirus Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 22. Head Office and Human Rotavirus Vaccine Production Site of Key Manufacturer
Table 23. Human Rotavirus Vaccine Market: Company Product Type Footprint
Table 24. Human Rotavirus Vaccine Market: Company Product Application Footprint
Table 25. Human Rotavirus Vaccine New Market Entrants and Barriers to Market Entry
Table 26. Human Rotavirus Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 27. Global Human Rotavirus Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 28. Global Human Rotavirus Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 29. Global Human Rotavirus Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 30. Global Human Rotavirus Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 31. Global Human Rotavirus Vaccine Average Price by Region (2019-2024) & (USD/Unit)
Table 32. Global Human Rotavirus Vaccine Average Price by Region (2025-2030) & (USD/Unit)
Table 33. Global Human Rotavirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 34. Global Human Rotavirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 35. Global Human Rotavirus Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 36. Global Human Rotavirus Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 37. Global Human Rotavirus Vaccine Average Price by Type (2019-2024) & (USD/Unit)
Table 38. Global Human Rotavirus Vaccine Average Price by Type (2025-2030) & (USD/Unit)
Table 39. Global Human Rotavirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 40. Global Human Rotavirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 41. Global Human Rotavirus Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 42. Global Human Rotavirus Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 43. Global Human Rotavirus Vaccine Average Price by Application (2019-2024) & (USD/Unit)
Table 44. Global Human Rotavirus Vaccine Average Price by Application (2025-2030) & (USD/Unit)
Table 45. North America Human Rotavirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 46. North America Human Rotavirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 47. North America Human Rotavirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 48. North America Human Rotavirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 49. North America Human Rotavirus Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 50. North America Human Rotavirus Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 51. North America Human Rotavirus Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 52. North America Human Rotavirus Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 53. Europe Human Rotavirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 54. Europe Human Rotavirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 55. Europe Human Rotavirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 56. Europe Human Rotavirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 57. Europe Human Rotavirus Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 58. Europe Human Rotavirus Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 59. Europe Human Rotavirus Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 60. Europe Human Rotavirus Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 61. Asia-Pacific Human Rotavirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 62. Asia-Pacific Human Rotavirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 63. Asia-Pacific Human Rotavirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 64. Asia-Pacific Human Rotavirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 65. Asia-Pacific Human Rotavirus Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 66. Asia-Pacific Human Rotavirus Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 67. Asia-Pacific Human Rotavirus Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 68. Asia-Pacific Human Rotavirus Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 69. South America Human Rotavirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 70. South America Human Rotavirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 71. South America Human Rotavirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 72. South America Human Rotavirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 73. South America Human Rotavirus Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 74. South America Human Rotavirus Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 75. South America Human Rotavirus Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 76. South America Human Rotavirus Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 77. Middle East & Africa Human Rotavirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 78. Middle East & Africa Human Rotavirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 79. Middle East & Africa Human Rotavirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 80. Middle East & Africa Human Rotavirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 81. Middle East & Africa Human Rotavirus Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 82. Middle East & Africa Human Rotavirus Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 83. Middle East & Africa Human Rotavirus Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 84. Middle East & Africa Human Rotavirus Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 85. Human Rotavirus Vaccine Raw Material
Table 86. Key Manufacturers of Human Rotavirus Vaccine Raw Materials
Table 87. Human Rotavirus Vaccine Typical Distributors
Table 88. Human Rotavirus Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Human Rotavirus Vaccine Picture
Figure 2. Global Human Rotavirus Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Human Rotavirus Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Rotarix Examples
Figure 5. RotaTeq Examples
Figure 6. Rotavac Examples
Figure 7. Rotavin-M1 Examples
Figure 8. Lanzhou lamb Examples
Figure 9. Others Examples
Figure 10. Global Human Rotavirus Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Human Rotavirus Vaccine Consumption Value Market Share by Application in 2023
Figure 12. Hospitals & Clinics Examples
Figure 13. Academic And Research Examples
Figure 14. Others Examples
Figure 15. Global Human Rotavirus Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Human Rotavirus Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Human Rotavirus Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 18. Global Human Rotavirus Vaccine Average Price (2019-2030) & (USD/Unit)
Figure 19. Global Human Rotavirus Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 20. Global Human Rotavirus Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 21. Producer Shipments of Human Rotavirus Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 22. Top 3 Human Rotavirus Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Top 6 Human Rotavirus Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Global Human Rotavirus Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 25. Global Human Rotavirus Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 26. North America Human Rotavirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Europe Human Rotavirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Asia-Pacific Human Rotavirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 29. South America Human Rotavirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 30. Middle East & Africa Human Rotavirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 31. Global Human Rotavirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 32. Global Human Rotavirus Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 33. Global Human Rotavirus Vaccine Average Price by Type (2019-2030) & (USD/Unit)
Figure 34. Global Human Rotavirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 35. Global Human Rotavirus Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 36. Global Human Rotavirus Vaccine Average Price by Application (2019-2030) & (USD/Unit)
Figure 37. North America Human Rotavirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 38. North America Human Rotavirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 39. North America Human Rotavirus Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 40. North America Human Rotavirus Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 41. United States Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Canada Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Mexico Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Europe Human Rotavirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 45. Europe Human Rotavirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 46. Europe Human Rotavirus Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 47. Europe Human Rotavirus Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 48. Germany Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. France Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. United Kingdom Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Russia Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Italy Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Asia-Pacific Human Rotavirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 54. Asia-Pacific Human Rotavirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 55. Asia-Pacific Human Rotavirus Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 56. Asia-Pacific Human Rotavirus Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 57. China Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Japan Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Korea Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. India Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Southeast Asia Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Australia Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. South America Human Rotavirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 64. South America Human Rotavirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 65. South America Human Rotavirus Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 66. South America Human Rotavirus Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 67. Brazil Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Argentina Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Middle East & Africa Human Rotavirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 70. Middle East & Africa Human Rotavirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 71. Middle East & Africa Human Rotavirus Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 72. Middle East & Africa Human Rotavirus Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 73. Turkey Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Egypt Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Saudi Arabia Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. South Africa Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Human Rotavirus Vaccine Market Drivers
Figure 78. Human Rotavirus Vaccine Market Restraints
Figure 79. Human Rotavirus Vaccine Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Human Rotavirus Vaccine in 2023
Figure 82. Manufacturing Process Analysis of Human Rotavirus Vaccine
Figure 83. Human Rotavirus Vaccine Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Figure 1. Human Rotavirus Vaccine Picture
Figure 2. Global Human Rotavirus Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Human Rotavirus Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Rotarix Examples
Figure 5. RotaTeq Examples
Figure 6. Rotavac Examples
Figure 7. Rotavin-M1 Examples
Figure 8. Lanzhou lamb Examples
Figure 9. Others Examples
Figure 10. Global Human Rotavirus Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Human Rotavirus Vaccine Consumption Value Market Share by Application in 2023
Figure 12. Hospitals & Clinics Examples
Figure 13. Academic And Research Examples
Figure 14. Others Examples
Figure 15. Global Human Rotavirus Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Human Rotavirus Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Human Rotavirus Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 18. Global Human Rotavirus Vaccine Average Price (2019-2030) & (USD/Unit)
Figure 19. Global Human Rotavirus Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 20. Global Human Rotavirus Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 21. Producer Shipments of Human Rotavirus Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 22. Top 3 Human Rotavirus Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Top 6 Human Rotavirus Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Global Human Rotavirus Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 25. Global Human Rotavirus Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 26. North America Human Rotavirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Europe Human Rotavirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Asia-Pacific Human Rotavirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 29. South America Human Rotavirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 30. Middle East & Africa Human Rotavirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 31. Global Human Rotavirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 32. Global Human Rotavirus Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 33. Global Human Rotavirus Vaccine Average Price by Type (2019-2030) & (USD/Unit)
Figure 34. Global Human Rotavirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 35. Global Human Rotavirus Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 36. Global Human Rotavirus Vaccine Average Price by Application (2019-2030) & (USD/Unit)
Figure 37. North America Human Rotavirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 38. North America Human Rotavirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 39. North America Human Rotavirus Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 40. North America Human Rotavirus Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 41. United States Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Canada Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Mexico Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Europe Human Rotavirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 45. Europe Human Rotavirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 46. Europe Human Rotavirus Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 47. Europe Human Rotavirus Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 48. Germany Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. France Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. United Kingdom Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Russia Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Italy Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Asia-Pacific Human Rotavirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 54. Asia-Pacific Human Rotavirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 55. Asia-Pacific Human Rotavirus Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 56. Asia-Pacific Human Rotavirus Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 57. China Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Japan Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Korea Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. India Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Southeast Asia Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Australia Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. South America Human Rotavirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 64. South America Human Rotavirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 65. South America Human Rotavirus Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 66. South America Human Rotavirus Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 67. Brazil Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Argentina Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Middle East & Africa Human Rotavirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 70. Middle East & Africa Human Rotavirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 71. Middle East & Africa Human Rotavirus Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 72. Middle East & Africa Human Rotavirus Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 73. Turkey Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Egypt Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Saudi Arabia Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. South Africa Human Rotavirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Human Rotavirus Vaccine Market Drivers
Figure 78. Human Rotavirus Vaccine Market Restraints
Figure 79. Human Rotavirus Vaccine Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Human Rotavirus Vaccine in 2023
Figure 82. Manufacturing Process Analysis of Human Rotavirus Vaccine
Figure 83. Human Rotavirus Vaccine Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
